Get the Stockscreener App
0.3926
0.93%
0.0036
Silo Pharma Inc stock is traded at $0.3926, with a volume of 43,173.
It is up +0.93% in the last 24 hours and down -11.16% over the past month.
SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's primary program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.
See More
Previous Close:
$0.389
Open:
$0.39
24h Volume:
43,173
Relative Volume:
0.12
Market Cap:
$5.23M
Revenue:
$72,100
Net Income/Loss:
$-3.60M
P/E Ratio:
-0.3299
EPS:
-1.19
Net Cash Flow:
$-3.37M
1W Performance:
+16.98%
1M Performance:
-11.16%
6M Performance:
-36.68%
1Y Performance:
-77.04%
1-Day Range:
$0.3847
$0.40
1-Week Range:
$0.3451
$0.40
52-Week Range:
$0.325
$2.1608
Silo Pharma Inc Stock (SILO) Company Profile
Name
Silo Pharma Inc
Sector
Industry
Phone
(718) 400-9031
Address
677 N. WASHINGTON BLVD, SARASOTA
Compare SILO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SILO
SILO PHARMA INC
|
1.71 | 17.96M | 0 | 0 | 0 | 0.00 |
|
MOBBW
Mobilicom Limited Warrants
|
3.65 | 4.83B | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
4.66 | 416.27M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
GOODO
Gladstone Commercial Corporation
|
20.75 | 372.90M | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
8.57 | 357.42M | 0 | 0 | 0 | 0.00 |
|
DWLD
Davis Select Worldwide ETF
|
47.51 | 0 | 0 | 0 | 0 | 0.00 |
Silo Pharma Inc Stock (SILO) Latest News
Weekly Recap: Is Silo Pharma Inc stock a safe haven asset2025 Growth vs Value & Weekly Momentum Picks - moha.gov.vn
Can Silo Pharma Inc. stock sustain institutional interest2025 Macro Impact & Pattern Based Trade Signal System - ulpravda.ru
ETF Watch: Why Silo Pharma Inc. stock could be next big winnerBond Market & Fast Gain Stock Trading Tips - ulpravda.ru
Why Silo Pharma Inc. stock could be next big winner2025 Earnings Surprises & Weekly High Return Stock Opportunities - ulpravda.ru
How Silo Pharma Inc. stock reacts to job market dataJuly 2025 Momentum & Real-Time Volume Spike Alerts - ulpravda.ru
Is Silo Pharma Inc. stock a safe haven assetMarket Growth Summary & Daily Volume Surge Trade Alerts - ulpravda.ru
Why Silo Pharma Inc. stock could see breakout soon2025 Momentum Check & Safe Entry Trade Reports - ulpravda.ru
What drives Soligenix Inc DOA0 stock priceMerger & Acquisition Updates & Buy Sell Timing Alerts - Early Times
Sheppard Mullin Advised Vanterra Ventures, Silo Pharma, Celularity And Others In Recent Deals - Mondaq
Silo Pharma (NASDAQ:SILO) Stock Price Down 2.9% – Here’s Why - Defense World
Silo Pharma signs LOI with Allucent for SPC-15 nasal spray clinical trials - Investing.com Nigeria
Silo Pharma Receives Extended Nasdaq Compliance Grace Period - The Globe and Mail
Silo Pharma Executes Letter of Intent with Allucent to Support Phase 1 Clinical Development of SPC-15 - GlobeNewswire
Silo Pharma receives extension from Nasdaq to regain minimum bid price compliance - Investing.com
Silo Pharma Received Notice of Noncompliance - TradingView — Track All Markets
How Silo Pharma Inc. stock responds to policy changesEconomic Indicators Overview & Small Entry Trading Portfolio - bollywoodhelpline.com
Is Silo Pharma Inc. stock a buy in volatile marketsQuarterly Risk Review & Low Risk Profit Maximizing Plans - Улправда
How Silo Pharma Inc. stock performs in rising dollar environmentJuly 2025 Macro Moves & Free Community Consensus Stock Picks - Улправда
Gains Report: Is Silo Pharma Inc. stock a buy in volatile markets2025 Trading Recap & AI Forecasted Entry and Exit Points - Улправда
Momentum Shift: How geopolitical tensions affect Silo Pharma Inc. stockRecession Risk & Real-Time Chart Pattern Alerts - Улправда
Can Silo Pharma Inc. stock resist market sell offs2025 Earnings Surprises & Daily Entry Point Alerts - Улправда
Why Silo Pharma Inc. stock remains resilientBuy Signal & High Accuracy Trade Signal Alerts - Улправда
Is Silo Pharma Inc. stock a safe investment in uncertain markets2025 Market Sentiment & Stepwise Trade Signal Guides - Улправда
VIX Spike: Is Silo Pharma Inc. stock a safe haven assetQuarterly Market Summary & High Win Rate Trade Tips - moha.gov.vn
Silo Pharma (SILO) CEO Eric Weisblum reports December insider share purchases - Stock Titan
Silo Pharma (NASDAQ:SILO) Stock Price Down 2.8% – What’s Next? - Defense World
How Silo Pharma Inc. stock performs during Fed tightening cycles2025 Top Decliners & Community Verified Trade Alerts - Newser
SILO Pharma (SILO) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Is Silo Pharma Inc a good long term investmentContrarian Investment Ideas & Free Record-Breaking Gains - earlytimes.in
Silo Pharma CEO Weisblum buys $735 in company stock By Investing.com - Investing.com Australia
Silo Pharma CEO Weisblum buys $735 in company stock - Investing.com India
[Form 4] Silo Pharma, Inc. Insider Trading Activity - Stock Titan
Will earnings trigger a reversal in Silo Pharma Inc.Market Risk Report & Smart Investment Allocation Tips - newser.com
Is Silo Pharma Inc. stock attractive for long term wealth buildingEntry Point & Long-Term Safe Return Strategies - newser.com
Is now a turning point for Silo Pharma Inc.July 2025 Analyst Calls & Accurate Intraday Trade Tips - newser.com
Silo Pharma selects Allucent to support PTSD treatment IND submission By Investing.com - Investing.com Nigeria
Evaluating Silo Pharma Inc. with trendline analysisMarket Rally & Weekly Stock Performance Updates - newser.com
Silo Pharma selects Allucent to support PTSD treatment IND submission - Investing.com
Silo Pharma partners with Allucent to support planned FDA Investigational New Drug application for SPC-15 as a therapeutic for PTSD - MarketScreener
Silo Pharma Partners With Allucent To Support Planned FDA Investigational New Drug Application For Spc-15 As A Therapeutic For Ptsd - TradingView
Silo Pharma Partners with Allucent to Support Planned FDA - GlobeNewswire
Can Silo Pharma Inc. stock deliver strong Q4 earningsNew Guidance & Free Safe Entry Trade Signal Reports - newser.com
Silo Pharma Inc Stock (SILO) Financials Data
Revenue
Net Income
Cash Flow
EPS
Silo Pharma Inc Stock (SILO) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Weisblum Eric | Chief Executive Officer |
Nov 20 '25 |
Buy |
0.37 |
1,000 |
370 |
210,932 |
| Weisblum Eric | Chief Executive Officer |
Nov 21 '25 |
Buy |
0.36 |
1,000 |
365 |
211,932 |
| Weisblum Eric | Chief Executive Officer |
Nov 18 '25 |
Buy |
0.40 |
7,500 |
3,025 |
205,432 |
| Weisblum Eric | Chief Executive Officer |
Nov 19 '25 |
Buy |
0.41 |
4,500 |
1,823 |
209,932 |
| Weisblum Eric | Chief Executive Officer |
May 27 '25 |
Buy |
0.43 |
10,000 |
4,329 |
197,932 |
0.90%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):